Chemotherapy regimens in advanced non-small-cell lung cancer: Recent randomized trials

Clinical Lung Cancer

Volumn 3, Issue SUPPL. 1, 2002, Pages S5-

  Belani, Chandra P ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

Chemotherapy; Cisplatin; Docetaxel; Gemcitabine; Genetic polymorphisms; Paclitaxel; Vinorelbine

Indexed keywords

ANGIOGENESIS INHIBITOR; BETA TUBULIN; CANCER VACCINE; CARBOPLATIN; CISPLATIN; DOCETAXEL; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; MITOMYCIN C; NAVELBINE; PACLITAXEL; PLATINUM DERIVATIVE; TAXANE DERIVATIVE; VINBLASTINE;

ADVANCED CANCER; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG CHOICE; DRUG EFFICACY; DRUG TOLERANCE; DRUG TOXICITY; EXCISION REPAIR; FEBRILE NEUTROPENIA; GENE THERAPY; GENETIC POLYMORPHISM; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; NAUSEA AND VOMITING; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0036241254     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/clc.2002.s.001     Document Type: Article

References (14)

1. An update on North American randomized studies in non-small cell lung cancer
2. New agents in the management of advanced non-small cell lung cancer
3. New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: A review of the literature and future directions
4. New combinations in the treatment of lung cancer: A time for optimism
5. Phase III randomized trial comparing three platinum-based doublets in advanced non-small cell lung cancer
6. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
7. A randomized study of gemcitabine with carboplatin (GC) versus mitomycin, vinblastine and cisplatin (MVP) or mitomycin C, ifosfamide and cisplatin (MIC) as first line chemotherapy in advanced non-small cell lung cancer (NSCLC)
8. Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study
9. Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: A multicenter phase II trial
10. Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A randomised multicentre trial
11. A EORTC randomized phase III trial of three chemotherapy regimens in advanced non-small cell lung cancer (NSCLC)
12. Prospective randomized study of four third generation chemotherapy regimens in patients (pts) with advanced non-small cell lung cancer: A Minnie Pearl Cancer Research Network Trial
13. Beta-tubulin mutations in circulating extracellular DNA of non-small-cell lung cancer (NSCLC) patients
14. Altered ERCC1 expression correlates with response to cisplatin (DDP) + gemcitabine (Gem) in non-small-cell lung cancer patients (pts)